Area postrema syndrome (APS) is one of the clinical presentations of neuromyelitis optica spectrum disorders (NMOSD) and has rarely been associated with glial fibrillary acidic protein (GFAP) antibodies [1]. The gene discussed is GFAP; the disease is autoimmune polyendocrinopathy.